XPH · State Street
State Street SPDR S&P Pharmaceuticals ETF
See how 64 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.
Core valuation
Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 99.88% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.
Largest reported holdings
| Holding | Weight | Trailing P/E | Trailing P/S |
|---|---|---|---|
| AMLXAMYLYX PHARMACEUTICALS INC | 4.06% | -20.57× | Unavailable |
| CRNXCRINETICS PHARMACEUTICALS IN | 3.49% | -17.96× | 213.74× |
| MBXMBX BIOSCIENCES INC | 3.03% | -26.11× | Unavailable |
| ATAIATAIBECKLEY INC | 2.76% | -4.08× | 583.07× |
| DFTXDEFINIUM THERAPEUTICS INC | 2.73% | -14.28× | Unavailable |
| OMEROMEROS CORP | 2.67% | 10.71× | 17.79× |
| ELVNENLIVEN THERAPEUTICS INC | 2.29% | -31.96× | Unavailable |
| CORTCORCEPT THERAPEUTICS INC | 2.21% | 227.37× | 14.84× |
| NUVBNUVATION BIO INC | 2.14% | -13.03× | 11.49× |
| ETONETON PHARMACEUTICALS INC | 2.12% | 117.10× | 14.07× |
Top 10 of 64 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.
Most similar funds
Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.
- IHE · iShares U.S. Pharmaceuticals ETF38.77% holdings overlap · NYSE Arca
- PJP · Invesco Pharmaceuticals ETF32.88% holdings overlap · US market
- PTH · Invesco Dorsey Wright Healthcare Momentum ETF15.96% holdings overlap · US market
- FTXH · First Trust Nasdaq Pharmaceuticals ETF15.66% holdings overlap · Nasdaq
- PSCH · Invesco S&P SmallCap Health Care ETF15.28% holdings overlap · US market
Sources and limitations
Holdings are sourced from State Street and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.
Open official holdings sourceResearch holdings date: 21 August 2026. Informational research, not investment advice.